Literature DB >> 3047228

Arterial chondroitin sulfate proteoglycan: localization with a monoclonal antibody.

M W Lark1, T K Yeo, H Mar, S Lara, I Hellström, K E Hellström, T N Wight.   

Abstract

We generated a monoclonal antibody (Mab) against a large chondroitin sulfate proteoglycan (CSPG) isolated from bovine aorta. This Mab (941) immunoprecipitates a CSPG synthesized by cultured monkey arterial smooth muscle cells. The immunoprecipitated CSPG is totally susceptible to chondroitinase ABC digestion and possesses a core glycoprotein of Mr approximately 400-500 KD. By use of immunofluorescence light microscopy and immunogold electron microscopy, the PG recognized by this Mab was shown to be deposited in the extracellular matrix of monkey arterial smooth muscle cell cultures in clusters which were not part of other fibrous matrix components and not associated with the cell's plasma membrane. With similar immunolocalization techniques, the CSPG antigen was found enriched in the intima and present in the medial portions of normal blood vessels, as well as in the interstitial matrix of thickened intimal lesions of atherosclerotic vessels. Immunoelectron microscopy revealed that this CSPG was confined principally to the space within the extracellular matrix not occupied by other matrix components, such as collagen and elastic fibers. These results indicate that this particular proteoglycan has a specific but restricted distribution in the extracellular matrix of arterial tissue.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3047228     DOI: 10.1177/36.10.3047228

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  9 in total

1.  A theory for water and macromolecular transport in the pulmonary artery wall with a detailed comparison to the aorta.

Authors:  Zhongqing Zeng; Kung-Ming Jan; David S Rumschitzki
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-12-23       Impact factor: 4.733

2.  Immunohistochemical staining for chondroitin sulphate and keratan sulphate. An evaluation of two monoclonal antibodies.

Authors:  S Daugaard; L Strange; T Schiødt
Journal:  Histochemistry       Date:  1991

3.  Selective deposits of versican in the extracellular matrix of restenotic lesions from human peripheral arteries.

Authors:  T N Wight; S Lara; R Riessen; R Le Baron; J Isner
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

4.  Proteoglycan distribution in lesions of atherosclerosis depends on lesion severity, structural characteristics, and the proximity of platelet-derived growth factor and transforming growth factor-beta.

Authors:  S P Evanko; E W Raines; R Ross; L I Gold; T N Wight
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

5.  Computational modelling suggests good, bad and ugly roles of glycosaminoglycans in arterial wall mechanics and mechanobiology.

Authors:  S Roccabianca; C Bellini; J D Humphrey
Journal:  J R Soc Interface       Date:  2014-08-06       Impact factor: 4.118

6.  Tissue variation of two large chondroitin sulfate proteoglycans (PG-M/versican and PG-H/aggrecan) in chick embryos.

Authors:  M Yamagata; T Shinomura; K Kimata
Journal:  Anat Embryol (Berl)       Date:  1993-05

7.  Alterations in proteoglycan synthesis common to healing wounds and tumors.

Authors:  T K Yeo; L Brown; H F Dvorak
Journal:  Am J Pathol       Date:  1991-06       Impact factor: 4.307

8.  Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome.

Authors:  A D Snow; H Mar; D Nochlin; R T Sekiguchi; K Kimata; Y Koike; T N Wight
Journal:  Am J Pathol       Date:  1990-11       Impact factor: 4.307

9.  Smooth muscle cell expression of extracellular matrix genes after arterial injury.

Authors:  S T Nikkari; H T Järveläinen; T N Wight; M Ferguson; A W Clowes
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.